Vimarsana
Biggest News Aggregation in the World

Page 9 - Elixir Equities News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Elixir Equities. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Elixir Equities Today - Breaking & Trending Today

bhel: Midcaps are where the action is; good trading opportunity in Bhel: Dipan Mehta - Vimarsana News

bhel: Midcaps are where the action is; good trading opportunity in Bhel: Dipan Mehta

"Companies like Bhel, which have the spare capacity, which have the technology, which have been more or less pre-qualified for many projects and orders are getting the true benefit of it. So, from a valuation perspective, from near-term prospects and also medium-term prospects, certainly there is a trading opportunity in Bhel and with the kind of momentum that is in the stock, it can easily rally by another 10-15% or so. But I would not like to invest in Bhel in the longer term."

multibaggers: Paytm, Zomato, PolicyBazaar can be the next Reliance, Titan or Asian Paints. Here's why - Vimarsana News

multibaggers: Paytm, Zomato, PolicyBazaar can be the next Reliance, Titan or Asian Paints. Here's why

"Paytm, Zomato, PolicyBazaar, Nykaa are entrepreneur driven companies and in India, you make a lot of money if you bet on the right entrepreneur, as we have seen with Reliance Industries, Asian Paints or Titan, for that matter, the Tata Group companies. These companies have all the right ingredients for a multibagger. If you remain patiently invested at some point of time, positive news flow will drive the stock prices higher."

pharma: Is the comeback in pharma here to stay? Should you buy expensive capital goods stocks? - Vimarsana News

pharma: Is the comeback in pharma here to stay? Should you buy expensive capital goods stocks?

"The next few quarters may certainly be very good for pharma companies. But these are no longer the secular growth stories which we have pursued back in the 2000 or 2010 era, when companies like Sun Pharma, Lupin, Dr. Reddy, Cipla were easily growing at 20% plus," says Dipan Mehta.

buying list: Got a buying list in this down cycle? Here are some of Dipan Mehta's favourites - Vimarsana News

buying list: Got a buying list in this down cycle? Here are some of Dipan Mehta's favourites

Investors in India are reportedly waiting to buy stocks after expecting a market correction. Dipan Mehta, Director of Elixir Equities, said 90% of people spoken to in the last two months were cautious, expecting a correction and the bulls have been waiting for an opportunity like this. In terms of sectors, Mehta believes there is a better chance of a decent return in inward-looking industries such as banking, capital goods, real estate, and hospitality, rather than export-oriented businesses.

indigo: Indigo can be bought at these levels or on dips: Dipan Mehta - Vimarsana News

indigo: Indigo can be bought at these levels or on dips: Dipan Mehta

Investment expert Dipan Mehta has advised investors to stick with Indigo, despite the company's ongoing struggles with Pratt & Whitney, and even if the stock appears expensive or negatively affected by crude prices. Mehta argued that while investing in aviation is risky, Indigo's position is strong and its strategy well-tested. While he would avoid metal , Mehta recommends investing in midcap stocks with a breakout business strategy that could return three to five times their value in the next two to three years.